Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-12-11
2000-11-21
Rotman, Alan L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546101, 546110, C07D22106, C07D47100, A61K 31435
Patent
active
061503754
ABSTRACT:
A series of benzoquinolin-3-ones are pharmaceuticals effective in treating conditions consequent on both Type I and Type II 5.alpha.-reductase.
REFERENCES:
patent: 5017568 (1991-05-01), Holt et al.
patent: 5030636 (1991-07-01), Imhof et al.
patent: 5239075 (1993-08-01), Audia et al.
patent: 5250539 (1993-10-01), Hirsch et al.
patent: 5300294 (1994-04-01), Johnson
Cannon, et al., J. Med. Chem., 22, 341-347 (1979).
Cannon, et al., J. Med. Chem, 19, 987-993 (1976).
Cannon, et al., J. Pharm. Sci., 74, 672-675 (1985).
Cannon, et al., Synthesis, 494-496 (1986).
Audia, et al., Tetra. Ltrs., 34, 7001-7004 (1993).
Hirsch, et al., Proc. Natl. Acad. Sci., 90, 5277-5281, (1993).
Jones, et al., J. Med. Chem., 36, 421-423 (1993).
Wikel, et al., Biorganic & Med. Chem. Ltrs., 3, 1157-1162 (1993).
Andersson, et al., Nature, 354, 159-161 (1991).
Jenkins, et al., J. Clin. Invest., 89, 293-300 (1992).
George, et al., Proc. Natl. Acad. Sci., 88, 8044-8047 (1991).
Andersson and Russel, Proc. Natl. Acad. Sci., 87, 3640-3644 (1990).
Starks and Liotta, "Phase Transfer Catalysts", Academic Press, N.Y., 1978, p. 217.
Koziara, et al., Synthesis, 527-529 (1979).
Klein, et al., J. Steroid Biochem., 30 (1-6), 119-130 (1988).
Kodahama, et al., JNCI, 74 (2), 475-486 (1985).
Brooks, et al., The Prostate, 18, 215-227 (1991).
Andriole, et al., The Prostate, 10, 189-197 (1987).
Gormley, Glenn J., Urol. Clin. North America, 18 (1), 93-98 (1991).
Audia James E.
Haehl Kevin L.
Kress Thomas J.
McQuaid Loretta A.
Neubauer Blake L.
Barrett Brian P.
Eli Lilly and Company
Rotman Alan L.
Sayles Michael J.
LandOfFree
5.alpha.-reductase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 5.alpha.-reductase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5.alpha.-reductase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1257553